A groundbreaking discovery which could change the lives of millions of bipolar sufferers forever has been announced.
The London Psychiatry Centre – which operates a clinic in the North East in partnership with Newcastle Premier Health – unveiled the exciting discovery in Cape Town, South Africa, on Sunday.
Applying a concept known as ‘precision medicine’, the breakthrough effectively predicts and targets the treatment of patients based on their genetic profile.
Centre representatives unveiled the discovery and findings from 20 cases – with type 2 and subthreshold bipolar disorder – in patients who have four or more mood changes in a year (rapid cycling). These conditions worsen with the use of antidepressants.
But the concept of precision medicine used a combination of rTMS (Repetitive Transcranial Magnetic Stimulation) and high dose of thyroid hormone, alongside targeted genetic testing for thyroid activating enzymes which ensures the patient suffers minimal, if any side effects.